SAO PAULO – Brazil on Wednesday for the first time approved the use of a marijuana derivative to treat people suffering from severe seizures and other conditions.
Directors of the country’s Health Surveillance Agency recognized the therapeutic properties of cannabidiol, saying it is now a “controlled” substance and no longer illegal.
It can now be used to treat epilepsy, multiple sclerosis and schizophrenia among other disorders.
READ MORE: Free pot for a year? There’s a contest for that (but it comes with some rules)
Cannabidiol is not produced in Brazil and the agency said it will draw up legislation permitting it to be imported.
“We had a technical and scientific discussion of a matter that is often influenced by other issues and biases,” the agency’s president Jaime Oliveira told reporters.
He said cannabidiol does not cause dependency nor psychoactive effects on users.
READ MORE: Some facts about Canada’s overhauled medical marijuana system
“It is a great first step but we still need easier and less expensive access to the medication,” said Margarete de Brito who gives cannabidiol to her 6-year-old daughter Sofia who was born with a genetic mutation that causes seizures.
Last month, the Federal Medical Council that regulates the medical profession in Brazil authorized neurologists and psychiatrists to prescribe cannabidiol to treat epileptic children and teenagers who do not respond to conventional treatment.
- Capital gains changes are ‘really fair,’ Freeland says, as doctors cry foul
- Ontario doctors offer solutions to help address shortage of family physicians
- ‘Dangerous message’: Experts slam anti-sunscreen claims circulating online
- ‘Trying not to die’: Tourism operators loaded with debt despite rising demand
Comments